The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Ricky O'Donnell has covered basketball at all levels for more than a decade at SB Nation. He's currently the Associate Director of Programing. Nikola Jokic has strapped the Denver Nuggets to his ...

A Delhi-based entrepreneur applauded an IndiGo cabin crew member's extraordinary heroism after she helped an elderly passenger recover as he began losing consciousness mid-air. In a LinkedIn post ...